The American Academy of Pediatrics attests that neurofeedback is a Level 1 - Best Support for attention and hyperactivity behaviors. Seven different types of ADHD exist, so some children/adults do not respond to medication. Neurofeedback is a drugless, non-invasive approach to treating neurological dysregulation syndromes, such as ADD/ADHD, anxiety, insomnia, depression, chronic Lyme disease and others.

The goal of neurofeedback is to transform an unhealthy, dysregulated brainwave pattern into a normal, healthy, organized pattern. Neurofeedback is based upon the principle that there is a normal pattern or brainwave activity and that the brain regulates itself based upon this pattern. More than 60 years of peer-reviewed, university-based research has demonstrated the efficacy of neurofeedback in addressing many neurological conditions.

Trained neurofeedback practitioners determine if an individual is a candidate for neurofeedback by performing a QEEG, then a program is developed to train the brain into normal patterns creating neuroplasticity. Neuroplasticity refers to the brain’s lifelong capacity to change and adapt specific neural pathways and synapses in response to the demands placed upon it. This is the reason why neurofeedback training is a permanent change for these patterns. Therefore, the behaviors that the ADD/ADHD/anxiety patient may be displaying due to the dysregulatory patterns will disappear and regulate, allowing them to make better decisions.

Dr. Frank H. Duffy, a professor and pediatric neurologist at Harvard Medical School, states, “Neurofeedback should play a major therapeutic role in many different areas. In my opinion, if any medication had demonstrated such a wide spectrum of efficacy, it would be universally accepted and widely used.”